17.14

0.12% -0.02

After Hours: 17.10 -0.04 -0.23%

Abrdn Life Sciences Investors (HQL)

Overview News Price History Discussions Forecast Dividend History

Abrdn Life Sciences Investors stock is traded at $17.14, with a volume of 60,552. It is down -0.12% in the last 24 hours and down -3.60% over the past month. abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.

Previous Close:

$17.16

Open:

$17.18

24h Volume:

60,552

Relative Volume:

0.58

Market Cap:

$521.19M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+2.15%

1M Performance:

-3.60%

6M Performance:

+1.96%

1Y Performance:

+33.59%

1-Day Range:

$17.01

$17.28

1-Week Range:

$16.48

$17.28

52-Week Range:

$12.34

$18.46

Abrdn Life Sciences Investors Stock (HQL) Company Profile

Name

Abrdn Life Sciences Investors

Sector

Financial (5884)

Industry

Closed-End Fund - Equity (109)

Phone

Address

Employee

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

HQL's Discussions on Twitter

Compare HQL vs DNP, UTG, ADX, UTF, GDV

Stocks	Price	Market Cap
HQL Abrdn Life Sciences Investors	17.14	521.80M
DNP Dnp Select Income Fund Inc	10.78	4.04B
UTG Reaves Utility Income Fund	41.96	3.81B
ADX Adams Diversified Equity Fund	25.34	3.11B
UTF Cohen Steers Infrastructure Fund Inc	27.40	3.06B
GDV Gabelli Dividend Income Trust	29.30	2.56B

Abrdn Life Sciences Investors Stock (HQL) Latest News

Jun 11, 2026

abrdn Healthcare Investors (HQH) Advances 1.44% as Sector Fund Tests Key Resistance ZoneHidden Order - newsline.com

Jun 11, 2026

abrdn Healthcare Opportunities Fund (THQ) Edges Higher Amid Sector StabilityGap and Go - newsline.com

Jun 11, 2026

New abrdn Life Sciences (NYSE: HQL) director files initial Form 3 - Stock Titan

Jun 11, 2026

Mahai Chris LaVictoire joins abrdn Healthcare (HQH) as reporting insider - Stock Titan

Jun 11, 2026

Jun 08, 2026

Abrdn Life Sciences Investors Reports Earnings Results for the Half Year Ended March 31, 2026 - marketscreener.com

Jun 08, 2026

Abrdn Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2026 - marketscreener.com

Jun 08, 2026

Jun 02, 2026

abrdn Healthcare Investors (HQH) Dips 2.74% as Sector Rotation Pressures the Closed-End FundRVOL Spike - newsline.com

Jun 02, 2026

May 29, 2026

Top abrdn Healthcare Investors (HQH) Competitors 2026 - MarketBeat

May 29, 2026

May 27, 2026

Aberdeen Investments U.S. Closed-End Funds Announce Results Of Annual Meeting Of Shareholders - Weekly Voice

May 27, 2026

ION closes the gap between trading and pipeline execution across North American gas markets with NatGasHub.com - Weekly Voice

May 27, 2026

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS – Company Announcement - Financial Times

May 27, 2026

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS - PR Newswire

May 27, 2026

May 25, 2026

abrdn Healthcare Investors (HQH) Slightly Lower as Shares Test Key Support LevelsWyckoff Accumulation - Newser

May 25, 2026

abrdn World Healthcare Fund Q1 2026 Commentary - Seeking Alpha

May 25, 2026

May 21, 2026